None listed
Conditions
Interventions
Drug : 1. All participants sign written informed consent on the day before the scheduled surgery.
2. On the day of surgery, eligible participants are randomly assigned to one of two groups: the triple
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Individuals undergoing gynecologic surgery performed laparoscopically - Adults aged =19 and <50 years -American Society of Anesthesiologists (ASA) Physical Status I–II; e.g., ASA I: no systemic disease; ASA II: well-controlled systemic disease managed medically or surgically (e.g., controlled hypertension, controlled diabetes)
Exclusion criteria
Exclusion criteria: -American Society of Anesthesiologists (ASA) Physical Status class III or higher -Pediatric patients aged =18 years -Adults aged =50 years -Diabetes mellitus -Pregnant or lactating women -Patients with contraindications to, or a history of allergy to, any study medications (investigational or control)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of postoperative nausea and vomiting (PONV) during 24hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of postoperative nausea and vomiting (PONV) during the PACU stay and at 6 hours after surgery;severity of postoperative nausea and vomiting (nrs, PONV scale);dose of rescue antiemetics within the first 24 h after surgery;pain intensity during the PACU stay and at 6 and 24 hours after surgery;all adverse events occurring within the first 24 h after surgery;Patient-reported quality of recovery at 24 h postoperatively (QoR-15K);advancement of oral intake within 24 hours after surgery;time to first flatus after surgery;24-hour postoperative opioid consumption | — |
Countries
Korea, Republic of
Contacts
Public ContactYu Jeong Bang
Samsung Medical Center
Outcome results
None listed